- Home
- ACRE vs GRAL Comparison
ACRE vs GRAL Comparison
Compare ACRE & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRE
- GRAL
- Stock Information
- Founded
- ACRE 2011
- GRAL 2016
- Country
- ACRE United States
- GRAL United States
- Employees
- ACRE N/A
- GRAL N/A
- Industry
- ACRE Real Estate Investment Trusts
- GRAL
- Sector
- ACRE Real Estate
- GRAL
- Exchange
- ACRE Nasdaq
- GRAL NYSE
- Market Cap
- ACRE 388.6M
- GRAL 449.6M
- IPO Year
- ACRE 2012
- GRAL N/A
- Fundamental
- Price
- ACRE $7.16
- GRAL $16.38
- Analyst Decision
- ACRE Hold
- GRAL Hold
- Analyst Count
- ACRE 7
- GRAL 1
- Target Price
- ACRE $7.10
- GRAL N/A
- AVG Volume (30 Days)
- ACRE 442.3K
- GRAL 603.0K
- Earning Date
- ACRE 11-07-2024
- GRAL 11-12-2024
- Dividend Yield
- ACRE 13.95%
- GRAL N/A
- EPS Growth
- ACRE N/A
- GRAL N/A
- EPS
- ACRE N/A
- GRAL N/A
- Revenue
- ACRE $39,423,000.00
- GRAL $117,669,000.00
- Revenue This Year
- ACRE N/A
- GRAL N/A
- Revenue Next Year
- ACRE $0.48
- GRAL N/A
- P/E Ratio
- ACRE N/A
- GRAL N/A
- Revenue Growth
- ACRE N/A
- GRAL 111.83
- 52 Week Low
- ACRE $6.25
- GRAL $12.33
- 52 Week High
- ACRE $11.24
- GRAL $23.36
- Technical
- Relative Strength Index (RSI)
- ACRE 60.42
- GRAL N/A
- Support Level
- ACRE $6.86
- GRAL N/A
- Resistance Level
- ACRE $7.15
- GRAL N/A
- Average True Range (ATR)
- ACRE 0.24
- GRAL 0.00
- MACD
- ACRE 0.05
- GRAL 0.00
- Stochastic Oscillator
- ACRE 81.25
- GRAL 0.00
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.